医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

腫瘍学

Puma Biotechnology’s Licensing Partner Specialised Therapeutics Asia Receives Regulatory Approval to Commercialize NERLYNX® (neratinib) for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer

Puma Biotechnology’s Licensing Partner Specialised Therapeutics Asia Receives Regulatory Approval to Commercialize NERLYNX® (neratinib) for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer

バイオテクノロジーヘルスケア腫瘍学製薬　 TimeLine: Extended Adjuvant Treatment of HER2-Positive Early Puma Biotechnology's Licensing Partner Specialised Receives Regulatory Approval to Commercialize

2019年03月18日

0

Kyowa Kirin Asia Pacific Announces Establishment of Subsidiary in Australia

Kyowa Kirin Asia Pacific Announces Establishment of Subsidiary in Australia

その他ヘルスバイオテクノロジーヘルスケア腫瘍学製薬　 TimeLine: Kyowa Kirin Asia Pacific Announces Establishment

2019年03月18日

0

オンコイミュニティー、機械学習を使用した新生抗原予測技術の臨床使用に対しCE-IVDマークを取得した初の企業に

オンコイミュニティー、機械学習を使用した新生抗原予測技術の臨床使用に対しCE-IVDマークを取得した初の企業に

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: CE-IVDマークオンコイミュニティー

2019年03月12日

0

Results by Genetron on Early-Stage Liver Cancer Detection in At-Risk Individuals Using Liquid Biopsy Are Published in PNAS

Results by Genetron on Early-Stage Liver Cancer Detection in At-Risk Individuals Using Liquid Biopsy Are Published in PNAS

ヘルスケアヘルス一般腫瘍学　 TimeLine: Individuals Using Liquid Biopsy Are Published Results by Genetron on Early-Stage Liver Cancer

2019年03月12日

0

Vedolizumab (Entyvio®) Achieves Superior Rates of Clinical Remission vs. Adalimumab (Humira®) in First Ever Head-to-Head Biologic Clinical Study in Ulcerative Colitis

Vedolizumab (Entyvio®) Achieves Superior Rates of Clinical Remission vs. Adalimumab (Humira®) in First Ever Head-to-Head Biologic Clinical Study in Ulcerative Colitis

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: Achieves Superior in First Ever Head-to-Head Biologic Clinical Study Rates of Clinical Remission

2019年03月09日

0

March is Lymphedema Awareness Month: ImpediMed Kicks Off Support on World Lymphedema Day, March 6; Co-sponsors Reception Featuring Actress/Lymphedema Survivor Kathy Bates, March 28, 2019

March is Lymphedema Awareness Month: ImpediMed Kicks Off Support on World Lymphedema Day, March 6; Co-sponsors Reception Featuring Actress/Lymphedema Survivor Kathy Bates, March 28, 2019

その他ヘルスヘルスケア医療機器医療用品理学療法腫瘍学　 TimeLine: Co-sponsors Reception Featuring ImpediMed Kicks Off Support on Lymphedema Survivor Kathy Bates March is Lymphedema Awareness Month World Lymphedema Day

2019年03月06日

0

Furukawa Electric Launches Single Cell Hunter for Functional Identification and Recovery of Live Single Cells

Furukawa Electric Launches Single Cell Hunter for Functional Identification and Recovery of Live Single Cells

バイオテクノロジーヘルスケア腫瘍学　 TimeLine: Furukawa Electric Launches Single Cell Hunter for Identification and Recovery of Live Single Cells

2019年02月25日

0

CHA Health Systems Subsidiary to Form the Largest Healthcare Network to Provide Premium Comprehensive Suite of Medical Services

CHA Health Systems Subsidiary to Form the Largest Healthcare Network to Provide Premium Comprehensive Suite of Medical Services

バイオテクノロジーヘルスケアヘルス一般マネージド・ケア医療管理病院腫瘍学　 TimeLine: CHA Health Systems Subsidiary to Form the to Provide Premium Comprehensive Suite of Medical

2019年02月21日

0

Owlstone Medical Partners with Shanghai Renji Hospital to Pioneer Breath Biopsy Lung Cancer Trial in China

Owlstone Medical Partners with Shanghai Renji Hospital to Pioneer Breath Biopsy Lung Cancer Trial in China

バイオテクノロジーヘルスケアヘルス一般理学療法病院腫瘍学臨床試験製薬　 TimeLine: Breath Biopsy Lung Cancer Trial in China Owlstone Medical Partners with Shanghai Renji

2019年02月20日

0

Owlstone Medical 与上海交通大学医学院附属仁济医院率先在中国进行肺癌呼吸活检临床测试

Owlstone Medical 与上海交通大学医学院附属仁济医院率先在中国进行肺癌呼吸活检临床测试

バイオテクノロジーヘルスケアヘルス一般理学療法病院腫瘍学臨床試験製薬　 TimeLine: Owlstone Medical

2019年02月20日

0